Immune hemolytic anemia associated with drug therapy

Blood Reviews
George Garratty

Abstract

Drug-induced immune hemolytic anemia (DIIHA) is rare; it can be mild or associated with acute severe hemolytic anemia (HA) and death. About 125 drugs have been implicated as the cause. The HA can be caused by drug-independent antibodies that are indistinguishable, in vitro and in vivo, from autoantibodies causing idiopathic warm type autoimmune hemolytic anemia (AIHA). More commonly, the antibodies are drug-dependent (i.e., will only react in vitro in the presence of the drug). The most common drugs to cause DIIHA are anti-microbials (e.g., cefotetan, ceftriaxone and piperacillin), which are associated with drug-dependent antibodies. The most common drug to cause AIHA is fludarabine. Finding out which drug is causing the problem and stopping that drug is the first approach to therapy. It is not easy to identify the drug interactions accurately in vitro; laboratories specializing in this area can be of great help.

References

Mar 1, 1975·The American Journal of Medicine·G Garratty, L D Petz
Aug 1, 1987·Transfusion Medicine Reviews·L D Petz
Aug 22, 1985·The New England Journal of Medicine·A Salama, C Mueller-Eckhardt
Jan 1, 1967·Annual Review of Medicine·J Dausset, L Contu
Mar 23, 1967·The New England Journal of Medicine·A F LoBuglio, J H Jandl
Apr 10, 1980·The New England Journal of Medicine·H H KirtlandD A Horwitz
Oct 1, 1993·Transfusion Medicine Reviews·G Garratty
May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B WeissJ C Byrd
Sep 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J HamblinD G Oscier
Jul 20, 1999·American Journal of Obstetrics and Gynecology·G GarrattyP A Arndt
Jul 27, 2002·Adverse Drug Reactions and Toxicological Reviews·Roopa ViraraghavanJanice Soreth
Sep 1, 1953·Annals of Internal Medicine·I SNAPPERL HOLLANDER
May 9, 1958·Science·A B LEYA CAHAN
Mar 6, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Alicia D AndersonFrederick J Angulo
May 26, 2004·Transfusion·Robertson D DavenportLouann R Dake
Sep 3, 2004·Pediatrics·Katherine M SheaUNKNOWN American Academy of Pediatrics Committee on Infectious Diseases
Dec 14, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Patricia M L A van den BemtAntoine C G Egberts
Apr 18, 2006·Seminars in Oncology·Terry J Hamblin
Nov 3, 2007·Pediatric Transplantation·Wendy WongMagali J Fontaine
Nov 29, 2007·Current Opinion in Hematology·Emmanuel Andrès, Frédéric Maloisel
Jul 29, 2008·Transfusion·Regina M LegerGeorge Garratty
Feb 25, 2009·Expert Opinion on Drug Safety·Abdulgabar Salama
May 5, 2009·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Susan T Johnson

❮ Previous
Next ❯

Citations

May 22, 2013·Archivum Immunologiae Et Therapiae Experimentalis·José Carlos Jaime-PérezDavid Gómez-Almaguer
May 11, 2013·International Journal of Hematology·Fei ChenJiang Wu
Apr 3, 2012·Malaria Journal·Annemarie R Kreeftmeijer-VegterPeter J de Vries
Oct 17, 2013·Indian Journal of Pharmacology·Vivek S GuleriaVelu Nair
Mar 31, 2015·Travel Medicine and Infectious Disease·Thierry RollingJakob P Cramer
Jan 1, 2011·Case Reports in Transplantation·Surekha Devi Allanki
Feb 7, 2014·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Jigar D ShrimaliHargovind L Trivedi
Jul 16, 2014·Case Reports in Infectious Diseases·Marwan Sheikh-Taha, Pascale Frenn
Mar 7, 2014·Archives of Disease in Childhood·José Manuel VagaceGuillermo Gervasini
Nov 28, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Hiroyuki SugiyamaAkitada Ichinose
Apr 17, 2012·Expert Opinion on Drug Safety·George Garratty
Jan 24, 2016·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Jane M ZhuBradley Monash
Jul 3, 2013·The Medical Clinics of North America·Jenny Wright, Douglas S Paauw
Sep 11, 2012·Journal of the American Academy of Dermatology·Yi-Chun ChenChia-Yu Chu
Jun 21, 2011·American Journal of Clinical Pathology·Arand PierceUNKNOWN Education Committee of the Academy of Clinical Laboratory Physicians and Scientists
Apr 9, 2011·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·D Rigal, F Meyer
May 20, 2015·Internal Medicine·Satoko OkaMasaharu Nohgawa
Jan 26, 2013·Transfusion·Beate MayerAbdulgabar Salama
Jul 14, 2011·British Journal of Haematology·Edeltraut GarbeHanife Kurtal
Mar 18, 2016·Internal Medicine·Takao Nagashima, Seiji Minota
Mar 18, 2016·Internal Medicine·Yukinori HaradaTsunesuke Kono
Apr 15, 2016·Hematology·Ekarat RattarittamrongLalita Norasetthada
May 28, 2013·Case Reports in Hematology·Aram BarbaryanAibek E Mirrakhimov
Jan 12, 2012·Case Reports in Medicine·Ghan-Shyam LohiyaVamsi Krishna
Jan 15, 2014·Autoimmunity Reviews·Garrett F BassJoseph M Tuscano
Feb 15, 2015·The Journal of Allergy and Clinical Immunology. in Practice·Benjamin T PrinceAnju T Peters
Aug 29, 2014·The Annals of Pharmacotherapy·Gal NeumanShinya Ito
Apr 22, 2017·The American Journal of Case Reports·James Tasch, Pedro Gonzalez-Zayaz
Jan 31, 2017·Archives of Pathology & Laboratory Medicine·Victoria Parker, Christopher A Tormey
Jun 18, 2017·Clinical Transplantation·Theoni Kanellopoulou
Apr 11, 2018·Expert Opinion on Drug Safety·Konstantinos Z VardakasMatthew E Falagas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

Expert Opinion on Drug Safety
George Garratty
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
Sigbjørn BerentsenElling Ulvestad
American Journal of Hematology
Bradley C Gehrs, Richard C Friedberg
© 2021 Meta ULC. All rights reserved